Duodenal mucosal resurfacing (DMR) — an investigational endoscopic procedure — helped patients maintain weight loss, and in some cases, even lose additional weight, 3 months after discontinuing GLP-1 receptor agonist therapy, initial results of the open-label, multistage REMAIN-1 trial showed. In addition, “the procedure was well tolerated, with only minor, transient TEAEs [treatment-emergent adverse events]
Complaints about hospital food are certainly not new, and Jell-O and fruit juice are often the butt of related jokes. But the Trump administration has recently upped the ante. It is urging the public to report hospitals and nursing homes that serve sugary drinks, nutrition shakes, or meals that it says don’t meet dietary guidelines
You don't have permission to access "http://www.medpagetoday.com/primarycare/uritheflu/121074" on this server. Reference #18.9177d917.1777813366.6dbceef7 https://errors.edgesuite.net/18.9177d917.1777813366.6dbceef7
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed the results of the FDA’s largest baby formula safety test on CBS News 24/7’s The Daily Report on April 29. She also discussed how women seeking treatment for menopause symptoms are facing a shortage of estrogen patches on CBS News’ CBS Mornings on April 27.